Personal Cfo Solutions, LLC Galapagos Nv Transaction History

Personal Cfo Solutions, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 02, 2020	SELL	$122.47 - $213.56 $230,978 - $402,774	-1,886 Closed	0 $0
Q2 2020 Aug 03, 2020	BUY	$185.52 - $231.25 $14,470 - $18,037	78 Added 4.31%	1,886 $372,000
Q1 2020 Apr 30, 2020	BUY	$143.0 - $274.03 $28,743 - $55,080	201 Added 12.51%	1,808 $354,000
Q4 2019 Feb 13, 2020	BUY	$146.12 - $215.82 $584 - $863	4 Added 0.25%	1,607 $332,000
Q3 2019 Nov 13, 2019	BUY	$130.44 - $187.64 $209,095 - $300,786	1,603 New	1,603 $245,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.76B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Personal Cfo Solutions, LLC, based on Form 13F filings with the SEC.

Stay updated on Personal Cfo Solutions, LLC with notifications on news.